Haider Mohamed, Megeed Zaki, Ghandehari Hamidreza
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
J Control Release. 2004 Feb 20;95(1):1-26. doi: 10.1016/j.jconrel.2003.11.011.
Genetic engineering methodology has enabled the synthesis of protein-based polymers with precisely controlled structures. Protein-based polymers have well-defined molecular weights, monomer compositions, sequences and stereochemistries. The incorporation of tailor-made motifs at specified locations by recombinant techniques allows the formation of hydrogels, sensitivity to environmental stimuli, complexation with drugs and nucleic acids, biorecognition and biodegradation. Accordingly, a special interest has emerged for the use of protein-based polymers for controlled drug and gene delivery, tissue engineering and other biomedical applications. This article is a review of genetically engineered polymers, their physicochemical characteristics, synthetic strategies used to produce them and their biomedical applications with emphasis on controlled release.
基因工程方法已能够合成具有精确可控结构的蛋白质基聚合物。蛋白质基聚合物具有明确的分子量、单体组成、序列和立体化学结构。通过重组技术在特定位置引入定制基序可形成水凝胶、对环境刺激产生敏感性、与药物和核酸形成复合物、实现生物识别和生物降解。因此,人们对将蛋白质基聚合物用于控释药物和基因递送、组织工程及其他生物医学应用产生了特别的兴趣。本文综述了基因工程聚合物、它们的物理化学特性、用于生产它们的合成策略以及它们在生物医学方面的应用,重点是控释。